Literature DB >> 19665630

Rheumatoid arthritis: strategy more important than agent.

Tuulikki Sokka1, Theodore Pincus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19665630     DOI： 10.1016/S0140-6736(09)61432-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

2.  [Therapy of rheumatoid arthritis with methotrexate. Claims data analysis of treatment patterns].

Authors:  J Zeidler; H Zeidler; J-M Graf von der Schulenburg
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

3.  Daily practice feasibility and effectiveness of treating long-standing rheumatoid arthritis to target with synthetic disease-modifying antirheumatic drugs: a prospective cohort study.

Authors:  Claiton Viegas Brenol; Rafael Mendonça Silva da Chakr; Nicole Pamplona Bueno Andrade; Mariana Toni; Ieda Maria Magalhães Laurindo; João Carlos Tavares Brenol; Ricardo Machado Xavier
Journal:  Clin Rheumatol       Date:  2015-03-15       Impact factor: 2.980

Review 4.  Treatment strategies are more important than drugs in the management of rheumatoid arthritis.

Authors:  Alexandros A Drosos; Eleftherios Pelechas; Paraskevi V Voulgari
Journal:  Clin Rheumatol       Date:  2020-02-22       Impact factor: 2.980

5.  Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.

Authors:  Glenn Haugeberg; Inger Johanne Widding Hansen; Dag Magnar Soldal; Tuulikki Sokka
Journal:  Arthritis Res Ther       Date:  2015-08-20       Impact factor: 5.156

Review 6.  Clinical outcome measures in juvenile idiopathic arthritis.

Authors:  Alessandro Consolaro; Gabriella Giancane; Benedetta Schiappapietra; Sergio Davì; Serena Calandra; Stefano Lanni; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-18       Impact factor: 3.054

7.  Simultaneous Treatment with Subcutaneous Injection of Golimumab and Intra-articular Injection of Triamcinolone Acetonide (K-Method) in Patients with Rheumatoid Arthritis Undergoing Switching of Biologics: Retrospective Case-Control Study.

Authors:  Katsuaki Kanbe; Junji Chiba; Yasuo Inoue; Masashi Taguchi; Akiko Yabuki; Tomohiko Deguchi
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-04-04

8.  Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010-2019 - a country with a national tender system for prescription of costly drugs.

Authors:  Alen Brkic; Andreas P Diamantopoulos; Espen Andre Haavardsholm; Bjørg Tilde Svanes Fevang; Lene Kristin Brekke; Liz Loli; Camilla Zettel; Erik Rødevand; Gunnstein Bakland; Pawel Mielnik; Glenn Haugeberg
Journal:  BMC Health Serv Res       Date:  2022-01-10       Impact factor: 2.655

Review 9.  Treat to Target (Drug-Free) Inactive Disease in JIA: To What Extent Is This Possible?

Authors:  Athimalaipet V Ramanan; Anne M Sage
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.